Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioCorRx (BICX) Other Non Operating Income (2017 - 2025)

BioCorRx (BICX) has disclosed Other Non Operating Income for 7 consecutive years, with $410551.0 as the latest value for Q4 2025.

  • Quarterly Other Non Operating Income rose 1100.39% to $410551.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $352940.0 through Dec 2025, up 314.42% year-over-year, with the annual reading at $223037.0 for FY2025, 235.5% up from the prior year.
  • Other Non Operating Income hit $410551.0 in Q4 2025 for BioCorRx, up from -$55000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $410551.0 in Q4 2025 to a low of -$338320.0 in Q4 2022.
  • Historically, Other Non Operating Income has averaged -$4010.1 across 5 years, with a median of -$34338.0 in 2023.
  • Biggest five-year swings in Other Non Operating Income: crashed 212.97% in 2022 and later surged 1100.39% in 2025.
  • Year by year, Other Non Operating Income stood at $299469.0 in 2021, then plummeted by 212.97% to -$338320.0 in 2022, then soared by 111.71% to $39613.0 in 2023, then crashed by 203.6% to -$41039.0 in 2024, then soared by 1100.39% to $410551.0 in 2025.
  • Business Quant data shows Other Non Operating Income for BICX at $410551.0 in Q4 2025, -$55000.0 in Q2 2025, and -$2611.0 in Q1 2025.